Latest in News & Research
Long-Term Improvement Seen With Ruxolitinib in Vitiligo
Improvement in facial/total Vitiligo Area Scoring Index seen with continued treatment from weeks 52 to 104
By Elana Gotkine (HealthDay News) | | March 28, 2023
Risk for Skin Cancer Higher for Adults With Atopic Dermatitis
Significantly increased risk seen for adults with moderate-to-severe versus mild atopic dermatitis
By Elana Gotkine (HealthDay News) | | March 27, 2023
Hispanic Patients More Likely to Have Melanoma Diagnosed at Stage IV
Significant differences seen for insurance status, income, education, Charlson-Deyo score, stage for Hispanic, White patients
By Dermsquared Editorial Team | | March 22, 2023
Topical Lovastatin Aids Disseminated Superficial Actinic Porokeratosis
Disease severity decreased by about 50 percent in the lovastatin-cholesterol and lovastatin-alone treatment groups
By Dermsquared Editorial Team | | March 22, 2023
Smoking Independently Tied to Higher Risk for Psoriasis
However, based on genetic analysis, smoking may not be a causal factor of psoriasis
By Lori Solomon (HealthDay News) | | March 21, 2023
Nicotinamide Does Not Prevent Keratinocyte Cancers in Organ Recipients
No difference seen in keratinocyte cancers or actinic keratoses for organ-transplant recipients receiving oral nicotinamide or placebo
By Elana Gotkine (HealthDay News) | | March 17, 2023
No Benefit Seen for Plasmapheresis First After Corticosteroids for SJS/TEN
Medical costs, LOS higher with plasmapheresis first versus intravenous immunoglobulin first for Stevens-Johnson syndrome and toxic epidermal necrolysis
By Dermsquared Editorial Team | | March 15, 2023
Can AI Tool Improve Quality of Patient-Submitted Images of Skin Disease?
Patient use of machine learning algorithm led to reduction in number of patients with poor-quality images
By Dermsquared Editorial Team | | March 15, 2023
Hair Regrowth Seen in Alopecia With Methotrexate Prednisone
About 31 percent of patients with recalcitrant alopecia areata totalis or universalis had complete hair regrowth
By Elana Gotkine (HealthDay News) | | March 15, 2023
Neoadjuvant, Adjuvant Pembrolizumab Beneficial in Resectable Melanoma
Event-free survival longer for those receiving neoadjuvant and adjuvant pembrolizumab versus adjuvant pembrolizumab only
By Physician's Briefing Staff | | March 10, 2023
Is Paroxetine Efficacious, Safe for Erythema of Rosacea?
Significantly greater proportion of patients achieved Clinical Erythema Assessment success with paroxetine versus placebo
By Dermsquared Editorial Team | | March 08, 2023
Microneedling, 5FU, Excimer Promising for Nonsegmental Vitiligo
Combination of 5FU after microneedling and excimer more suitable for localized, focal vitiligo
By Dermsquared Editorial Team | | March 08, 2023
Most Patients Like Having Access to Dermatology Clinic Notes
Concerns were few and included not understanding notes or abbreviations
By Lori Solomon (HealthDay News) | | March 08, 2023
Burden of Alopecia Areata Significant in the United States
Standardized prevalence highest in those aged 30 to 39, 40 to 49 years; Asians, Blacks, Hispanic/Latinos have increased prevalence ratios
By Elana Gotkine (HealthDay News) | | March 06, 2023
Prevalence of Alopecia Areata Increased From 2016 to 2019 in the United States
Prevalence and incidence higher for females versus males, adults versus children and teens, in Northeast versus other regions
By Dermsquared Editorial Team | | March 01, 2023
2005 to 2015 Saw Increase in Prevalence of Total Body Skin Exams
Only race/ethnicity with increase was non-Hispanic Whites; increases seen for those aged 31 to 40, 51 to 64 years
By Dermsquared Editorial Team | | March 01, 2023
Psoriasis Tied to Elevated Risk for Celiac Disease
People with psoriasis have double the odds of celiac disease versus people without psoriasis
By Lori Solomon (HealthDay News) | | February 28, 2023
AAAAI: Black Children With Eczema More Likely to Have Asthma
Black children with asthma less likely to have seen an allergist, more likely to lack prior inhalant allergy testing
By Elana Gotkine (HealthDay News) | | February 27, 2023
Methotrexate Linked to Increased Risk for Skin Cancer
When restricting analysis to patients with psoriasis, methotrexate was only associated with basal cell carcinoma
By Elana Gotkine (HealthDay News) | | February 23, 2023
1997 to 2018 Saw Increase in Prevalence of Eczema in Children
Average annual percentage change of prevalence was lower in White versus Black and multiracial children
By Dermsquared Editorial Team | | February 22, 2023
Reflectance Confocal Microscopy Agrees With Histopathology in Lentigo Maligna
Good agreement seen between RCM and histopathology for patients with lentigo maligna/lentigo maligna melanoma undergoing staging excision
By Dermsquared Editorial Team | | February 22, 2023
AI Model Differentiates Scalp Psoriasis From Seborrheic Dermatitis
Use of deep learning model improves diagnostic performance among nonproficient doctors
By Elana Gotkine (HealthDay News) | | February 16, 2023
Is Oxymetazoline Cream Effective for Erythema-Associated Rosacea?
Review shows once-daily oxymetazoline cream 1.0 percent has noticeable effect on improving rosacea erythema
By Dermsquared Editorial Team | | February 15, 2023
24 of 1200
Headline from the Week of February 09 - 15, 2026
Second Annual National Cancer Database Report Presented for 2022
By Elana Gotkine (HealthDay News) | | February 11, 2026
Presurgical Pembrolizumab Beneficial for Desmoplastic Melanoma
By Elana Gotkine (HealthDay News) | | February 11, 2026